Published in J Biol Chem on March 14, 2003
Selection for a dominant oncogene and large male size as a risk factor for melanoma in the Xiphophorus animal model. Mol Ecol (2010) 1.49
ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling. Cell Signal (2008) 1.27
Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor. Mol Cell Biol (2006) 1.12
Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors. Neoplasia (2012) 1.04
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol (2010) 0.99
Central role of the EGF receptor in neurometabolic aging. Int J Endocrinol (2012) 0.88
Endothelial cell-specific molecule 2 (ECSM2) localizes to cell-cell junctions and modulates bFGF-directed cell migration via the ERK-FAK pathway. PLoS One (2011) 0.87
Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer. Cancers (Basel) (2011) 0.86
Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways. Acta Pharmacol Sin (2010) 0.86
Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A (2016) 0.86
Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1. Mol Endocrinol (2009) 0.84
Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells. Mol Endocrinol (2011) 0.83
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. Am J Physiol Endocrinol Metab (2008) 0.82
GH modulates hepatic epidermal growth factor signaling in the mouse. J Endocrinol (2009) 0.82
Synergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptors. Cell Signal (2010) 0.81
Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system. Biochim Biophys Acta (2008) 0.80
Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling. Endocrinology (2013) 0.79
Structural and functional characterization of two alternative splicing variants of mouse Endothelial Cell-Specific Chemotaxis Regulator (ECSCR). Int J Mol Sci (2012) 0.78
Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver. Cell Signal (2011) 0.78
Cancer. Adv Exp Med Biol (2005) 0.77
Prolactin and growth hormone affect metaphase-II chromosomes in aging oocytes via cumulus cells using similar signaling pathways. Front Genet (2015) 0.75
Intracellular signaling transduction pathways triggered by a well-known anti-GHR monoclonal antibody, Mab263, in vitro and in vivo. Int J Mol Sci (2014) 0.75
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome. Cancer Res (2007) 3.85
Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol (2012) 2.63
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med (2009) 2.62
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med (2010) 2.44
Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol (2011) 2.43
Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol (2014) 2.42
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys (2012) 2.17
Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells. Arthritis Rheum (2012) 2.03
E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells (2010) 1.97
Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis. Ann Surg (2016) 1.86
A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. Blood (2011) 1.84
Automatically generating gene summaries from biomedical literature. Pac Symp Biocomput (2006) 1.83
miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev (2010) 1.80
Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int (2011) 1.70
Noninvasive bioluminescence imaging in small animals. ILAR J (2008) 1.59
Transcriptome sequencing and de novo analysis for Ma bamboo (Dendrocalamus latiflorus Munro) using the Illumina platform. PLoS One (2012) 1.51
Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047). J Med Chem (2009) 1.50
Complex threshold method for identifying pixels that contain predominantly noise in magnetic resonance images. J Magn Reson Imaging (2008) 1.47
Removing background phase variations in susceptibility-weighted imaging using a fast, forward-field calculation. J Magn Reson Imaging (2009) 1.39
Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep (2011) 1.38
Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol (2011) 1.35
Pharmacokinetics, pharmacodynamics, metabolism, distribution, and excretion of carfilzomib in rats. Drug Metab Dispos (2011) 1.35
Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. J Med Chem (2005) 1.32
Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Invest (2010) 1.30
Structure and mechanism of the uracil transporter UraA. Nature (2011) 1.29
ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling. Cell Signal (2008) 1.27
Mode of growth hormone action in osteoblasts. J Biol Chem (2007) 1.27
IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One (2012) 1.25
Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis. Cancer Res (2008) 1.21
Start codon targeted polymorphism for evaluation of functional genetic variation and relationships in cultivated peanut (Arachis hypogaea L.) genotypes. Mol Biol Rep (2010) 1.19
Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology (2008) 1.17
Molecular mechanism of photoactivation and structural location of the cyanobacterial orange carotenoid protein. Biochemistry (2013) 1.13
DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target. Cancer Res (2010) 1.12
Stk40 links the pluripotency factor Oct4 to the Erk/MAPK pathway and controls extraembryonic endoderm differentiation. Proc Natl Acad Sci U S A (2010) 1.12
The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol Endocrinol (2013) 1.11
New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values. Magn Reson Med (2007) 1.10
Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities. Lung Cancer (2013) 1.07
Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol Endocrinol (2003) 1.05
More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Cell Res (2009) 1.04
Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements. Mol Endocrinol (2004) 1.04
CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res (2009) 1.04
Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site. J Biol Chem (2002) 1.03
Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure. Int J Cardiol (2009) 1.01
Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor. PLoS One (2009) 1.01
Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis. Respir Med (2009) 1.00
Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case-control study in an Indian population. Cancer Epidemiol (2010) 1.00
Determinants of growth hormone receptor down-regulation. Mol Endocrinol (2007) 1.00
Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol (2003) 1.00
Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Mol Endocrinol (2008) 0.99
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol (2010) 0.99
Insulin enhances growth hormone induction of the MEK/ERK signaling pathway. J Biol Chem (2005) 0.98
A fast workflow for identification and quantification of proteomes. Mol Cell Proteomics (2013) 0.98
Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol (2008) 0.98
Janus kinase 2 enhances the stability of the mature growth hormone receptor. Endocrinology (2005) 0.98
Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation. Mol Endocrinol (2007) 0.98
Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. Mol Endocrinol (2011) 0.96
Partial redirection of transgenic human growth hormone secretion from rat salivary glands. Hum Gene Ther (2005) 0.96
Different developmental potential of pluripotent stem cells generated by different reprogramming strategies. J Mol Cell Biol (2011) 0.95
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis. EMBO Mol Med (2014) 0.95
Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage. J Biol Chem (2005) 0.95
High-efficiency somatic reprogramming induced by intact MII oocytes. Cell Res (2010) 0.95
Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys (2013) 0.95
Expression profiling of salinity-alkali stress responses by large-scale expressed sequence tag analysis in Tamarix hispid. Plant Mol Biol (2007) 0.94
Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology (2007) 0.94
Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery. Cancer (2012) 0.94
Caveolar and lipid raft localization of the growth hormone receptor and its signaling elements: impact on growth hormone signaling. J Biol Chem (2004) 0.94
Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis. Am J Pathol (2006) 0.94
Irreversible electroporation: an in vivo study with dorsal skin fold chamber. Ann Biomed Eng (2012) 0.93
Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering. Mol Endocrinol (2007) 0.93
Impairment of liver GH receptor signaling by fasting. Endocrinology (2002) 0.93
Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis. PLoS One (2012) 0.93
Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats. Mech Ageing Dev (2004) 0.93
Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci (2003) 0.92
ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. J Cell Physiol (2010) 0.92
Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol (2012) 0.92
Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis. Cancer Res (2007) 0.92
Janus kinase 2 influences growth hormone receptor metalloproteolysis. Endocrinology (2006) 0.91
Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7. Am J Physiol Lung Cell Mol Physiol (2013) 0.91
Protein predictive signatures for lymph node metastasis of gastric cancer. Int J Cancer (2012) 0.90
Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis. J Infect (2009) 0.90
Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells. Endocrinology (2004) 0.90
Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis. J Infect (2011) 0.89
Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. Cancer (2011) 0.89